Literature DB >> 27160198

Chronic Interactions Between Carotid Baroreceptors and Chemoreceptors in Obesity Hypertension.

Thomas E Lohmeier1, Radu Iliescu1, Ionut Tudorancea1, Radu Cazan1, Adam W Cates1, Dimitrios Georgakopoulos1, Eric D Irwin1.   

Abstract

Carotid bodies play a critical role in protecting against hypoxemia, and their activation increases sympathetic activity, arterial pressure, and ventilation, responses opposed by acute stimulation of the baroreflex. Although chemoreceptor hypersensitivity is associated with sympathetically mediated hypertension, the mechanisms involved and their significance in the pathogenesis of hypertension remain unclear. We investigated the chronic interactions of these reflexes in dogs with sympathetically mediated, obesity-induced hypertension based on the hypothesis that hypoxemia and tonic activation of carotid chemoreceptors may be associated with obesity. After 5 weeks on a high-fat diet, the animals experienced a 35% to 40% weight gain and increases in arterial pressure from 106±3 to 123±3 mm Hg and respiratory rate from 8±1 to 12±1 breaths/min along with hypoxemia (arterial partial pressure of oxygen=81±3 mm Hg) but eucapnia. During 7 days of carotid baroreflex activation by electric stimulation of the carotid sinus, tachypnea was attenuated, and hypertension was abolished before these variables returned to prestimulation values during a recovery period. After subsequent denervation of the carotid sinus region, respiratory rate decreased transiently in association with further sustained reductions in arterial partial pressure of oxygen (to 65±2 mm Hg) and substantial hypercapnia. Moreover, the severity of hypertension was attenuated from 125±2 to 116±3 mm Hg (45%-50% reduction). These findings suggest that hypoxemia may account for sustained stimulation of peripheral chemoreceptors in obesity and that this activation leads to compensatory increases in ventilation and central sympathetic outflow that contributes to neurogenically mediated hypertension. Furthermore, the excitatory effects of chemoreceptor hyperactivity are abolished by chronic activation of the carotid baroreflex.
© 2016 American Heart Association, Inc.

Entities:  

Keywords:  baroreflex; blood pressure; carotid bodies; hypertension; obesity; sympathetic nervous system

Mesh:

Year:  2016        PMID: 27160198      PMCID: PMC4900898          DOI: 10.1161/HYPERTENSIONAHA.116.07232

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  50 in total

1.  Prolonged activation of the baroreflex abolishes obesity-induced hypertension.

Authors:  Thomas E Lohmeier; Terry M Dwyer; Eric D Irwin; Martin A Rossing; Robert S Kieval
Journal:  Hypertension       Date:  2007-04-16       Impact factor: 10.190

2.  Pressor responses to electrical stimulation of the carotid sinus nerve in cats.

Authors:  E NEIL; C R M REDWOOD; A SCHWEITZER
Journal:  J Physiol       Date:  1949-09       Impact factor: 5.182

3.  Systemic and renal-specific sympathoinhibition in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu; Boshen Liu; Jeffrey R Henegar; Christine Maric-Bilkan; Eric D Irwin
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

4.  Waist-to-hip ratio is associated with pulmonary gas exchange in the morbidly obese.

Authors:  Gerald S Zavorsky; Juan M Murias; Do Jun Kim; Jennifer Gow; Jean-Loup Sylvestre; Nicolas V Christou
Journal:  Chest       Date:  2007-02       Impact factor: 9.410

5.  Improved assay for plasma dihydroxyphenylacetic acid and other catechols using high-performance liquid chromatography with electrochemical detection.

Authors:  C Holmes; G Eisenhofer; D S Goldstein
Journal:  J Chromatogr B Biomed Appl       Date:  1994-03-04

Review 6.  The sympathetic nervous system in obesity hypertension.

Authors:  Thomas E Lohmeier; Radu Iliescu
Journal:  Curr Hypertens Rep       Date:  2013-08       Impact factor: 5.369

Review 7.  Baroreflex activation: from mechanisms to therapy for cardiovascular disease.

Authors:  Radu Iliescu; Ionut Tudorancea; Thomas E Lohmeier
Journal:  Curr Hypertens Rep       Date:  2014-08       Impact factor: 5.369

8.  Prolonged activation of the baroreflex produces sustained hypotension.

Authors:  Thomas E Lohmeier; Eric D Irwin; Martin A Rossing; David J Serdar; Robert S Kieval
Journal:  Hypertension       Date:  2004-01-05       Impact factor: 10.190

9.  Subcutaneous obesity is not associated with sympathetic neural activation.

Authors:  Guy E Alvarez; Tasha P Ballard; Stacy D Beske; Kevin P Davy
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-02-26       Impact factor: 4.733

10.  Sustained suppression of sympathetic activity and arterial pressure during chronic activation of the carotid baroreflex.

Authors:  Thomas E Lohmeier; Radu Iliescu; Terry M Dwyer; Eric D Irwin; Adam W Cates; Martin A Rossing
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-05-28       Impact factor: 4.733

View more
  13 in total

1.  Obesity, Hypoxemia, and Hypertension: Mechanistic Insights and Therapeutic Implications.

Authors:  Allyn L Mark; Virend K Somers
Journal:  Hypertension       Date:  2016-05-09       Impact factor: 10.190

Review 2.  Pathophysiology and Potential Non-Pharmacologic Treatments of Obesity or Kidney Disease Associated Refractory Hypertension.

Authors:  Thierry H Le Jemtel; William Richardson; Rohan Samson; Abhishek Jaiswal; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2017-02       Impact factor: 5.369

Review 3.  Lifestyle interventions for the prevention and treatment of hypertension.

Authors:  Pedro L Valenzuela; Pedro Carrera-Bastos; Beatriz G Gálvez; Gema Ruiz-Hurtado; José M Ordovas; Luis M Ruilope; Alejandro Lucia
Journal:  Nat Rev Cardiol       Date:  2020-10-09       Impact factor: 32.419

4.  Prolonged Baroreflex Activation Abolishes Salt-Induced Hypertension After Reductions in Kidney Mass.

Authors:  Drew A Hildebrandt; Eric D Irwin; Thomas E Lohmeier
Journal:  Hypertension       Date:  2016-10-24       Impact factor: 10.190

Review 5.  Obesity, kidney dysfunction and hypertension: mechanistic links.

Authors:  John E Hall; Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Michael E Hall
Journal:  Nat Rev Nephrol       Date:  2019-06       Impact factor: 28.314

6.  Leptin Induces Hypertension Acting on Transient Receptor Potential Melastatin 7 Channel in the Carotid Body.

Authors:  Mi-Kyung Shin; Candela Caballero Eraso; Yun-Ping Mu; Chenjuan Gu; Bonnie H Y Yeung; Lenise J Kim; Xiao-Ru Liu; Zhi-Juan Wu; Omkar Paudel; Luis E Pichard; Machiko Shirahata; Wan-Yee Tang; James S K Sham; Vsevolod Y Polotsky
Journal:  Circ Res       Date:  2019-09-23       Impact factor: 17.367

Review 7.  Obesity-Induced Hypertension: Brain Signaling Pathways.

Authors:  Jussara M do Carmo; Alexandre A da Silva; Zhen Wang; Taolin Fang; Nicola Aberdein; Cecilia E P de Lara Rodriguez; John E Hall
Journal:  Curr Hypertens Rep       Date:  2016-07       Impact factor: 5.369

Review 8.  Obesity and Pulmonary Hypertension.

Authors:  Karnika Ayinapudi; Twinkle Singh; Ayush Motwani; Thierry H Le Jemtel; Suzanne Oparil
Journal:  Curr Hypertens Rep       Date:  2018-10-05       Impact factor: 5.369

Review 9.  Anti-Inflammatory Effects of Melatonin in Obesity and Hypertension.

Authors:  Natalia Jorgelina Prado; León Ferder; Walter Manucha; Emiliano Raúl Diez
Journal:  Curr Hypertens Rep       Date:  2018-05-09       Impact factor: 5.369

Review 10.  Obesity, kidney dysfunction, and inflammation: interactions in hypertension.

Authors:  John E Hall; Alan J Mouton; Alexandre A da Silva; Ana C M Omoto; Zhen Wang; Xuan Li; Jussara M do Carmo
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.